Syneron Medical Ltd. (
Q3 2011 Earnings Call
November 10, 2011 8:30 AM ET
Zack Kubow – The Ruth Group, IR
Lou Scafuri – Chief Executive Officer
Asaf Alperovitz – Chief Financial Officer
Shimon Eckhouse – Chairman
Rich Newitter – Leerink Swann
Anthony Vendetti – Maxim Group
Dalton Chandler – Needham
Good day, ladies and gentlemen. And welcome to the Syneron Medical Third Quarter 2011 Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. (Operator Instructions)
As a reminder, this conference is being recorded. I would now like to turn the call over to your host Zack Kubow. Please go ahead, sir.
Thank you, Operator. I’d like to welcome you to Syneron Medical’s third quarter 2011 conference call.
Statements on this call may be forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, relating to the company’s future events or future performance, including statements respect to Syneron’s expectations regarding, but not limited to the financial forecast for 2011, the launch of new products and the maintenance of leadership position in core and non-core markets.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the company’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in any forward-looking statements.